by Reuters on (#6YZ3K)
Pharma group names Maziar Mike Doustdar as new CEO as it seeks to convince investors it is not lagging behind rival Eli Lily
| Link | https://www.theguardian.com/world |
| Feed | http://feeds.theguardian.com/theguardian/world/rss |
| Copyright | Guardian News and Media Limited or its affiliated companies. All rights reserved. 2026 |
| Updated | 2026-01-03 06:00 |